摘要
目的:评估宫颈HPV感染应用重组人工干扰素α2b阴道泡腾胶囊(辛复宁)的临床治疗效果,以此帮助患者临床合理选择用药。方法:选择我院门诊收治的宫颈高危型人乳头瘤病毒(HPV)患者120例进行研究,根据随机数字法,将患者分成两组,分别为对照组与观察组,应用不同的治疗方法,各60例患者。其中对照组应用甲硝唑栓治疗,观察组应用辛复宁治疗,治疗后的第3个月、第9个月进行复查,对比两组治疗效果。结果:观察组治疗第3个月、第9个月有效率明显比对照组高,两组对比差异显著(P<0.05);观察组再次感染率明显低于对照组,两组对比差异显著(P<0.05);两组患者用药后均未出现明显的不良反应。结论:宫颈HPV感染应用辛复宁治疗效果理想,明显降低了再次感染率,而且用药后未见明显的不良反应,治疗安全可靠,建议推广应用。
objective:to evaluate clinical curative effect of the cervical HPV infection application of recombinant human interferon alpha 2b vaginal effervescent capsule(XinFuNing).Methods:120 cases were admitted outpatient service type of high-risk human papilloma virus(HPV),according to the random number method,divided into two groups,control group and observation group,respectively each 60 cases.the control group used metronidazole suppository treatment,observation group used XinFuNing treatment,treatment after 3 months,9 months in the process of reviewing compared therapeutic effect of two groups.Results:the 3 months,9 months efficiency of treatment group was significantly higher than the control group(P 0.05);Infection rates again observation group was obviously lower than the control group(P 0.05);there were not obvious adverse reaction occurred of two groups.Conclusion:cervical HPV infection XinFuNing treatment effect is ideal,significantly reduced the rates again,and no obvious adverse reaction of the medicine,safe and reliable treatment,suggest the popularization and application.
出处
《中外女性健康研究》
2016年第23期3-4,共2页
Women's Health Research
关键词
宫颈HPV感染
重组人工干扰素α2b
阴道泡腾胶囊
cervical HPV infection
Recombinant human interferon alpha 2b
Vaginal effervescent capsules